FCN1 and neoplasm: Upregulation of FCN1 potentially enhances immune cell activation (e.g., CD4 T cells, CD8 T cells, NK cells, Th1 cells, and MDSC) and their infiltration into tumors by modulating the expression of chemokines, their receptors, and cell adhesion molecules in the tumor microenvironment.